Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer

被引：0
|
作者：
Alessandro Di Federico
Ilaria Ricciotti
Valentina Favorito
Sandra Vietti Michelina
Pietro Scaparone
Giulio Metro
Andrea De Giglio
Federica Pecci
Giuseppe Lamberti
Chiara Ambrogio
Biagio Ricciuti
机构：
[1] Dana-Farber Cancer Institute,Lowe Center for Thoracic Oncology
[2] University of Bologna,Department of Medical and Surgical Sciences
[3] University of Torino,Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology, Center
[4] Santa Maria Della Misericordia Hospital,Medical Oncology
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Non-small cell lung cancer; KRAS inhibitors; KRAS; Adagrasib; Sotorasib; Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1017 / 1029
页数：12
相关论文
共 50 条
  • [21] Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer
    Yu Zhang
    Liang Liu
    Jinpeng Pei
    Zhiqiang Ren
    Yan Deng
    Ker Yu
    Oncogene, 2024, 43 : 668 - 681
  • [22] Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
    Adachi, Yuta
    Ito, Kentaro
    Hayashi, Yuko
    Kimura, Ryo
    Tan, Tuan Zea
    Yamaguchi, Rui
    Ebi, Hiromichi
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5962 - 5973
  • [23] Suppression of mutant Kirsten-RAS (KRAS G12C) non-small cell lung cancer (NSCLC) resistance to KRAS G12C inhibitors by dual inhibition of hepatocyte growth factor receptor (MET) and V-ATPase
    Rosell, R.
    Gomez-Vazquez, J. L.
    Lewintre, E. Jantus
    Ito, M.
    Cao, P.
    Cai, X.
    Xing, B.
    Farinas, S. Calabuig
    Cardona, A. F.
    Rodriguez, J. K.
    Jordan, M. Marco
    Valdunciel, C. Pedraz
    Molina-Vila, M. A.
    Codony-Servat, J.
    Dantes, Z.
    Aguilar, A.
    Sullivan, I. G.
    Horno, I. Moya
    Cirera, L.
    Gonzalez-Cao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S149 - S149
  • [24] Non-genetic determinants driving sub-clonal resistance to KRAS G12C combination therapies in KRAS mutant non-small cell lung cancer
    Li, Chendi
    Graser, Christopher J.
    Qin, Qian
    Syed, Usman M.
    Karakyriakou, Barbara
    Clark, Sarah E.
    Saiki, Anne Y.
    Hughes, Paul E.
    Ott, Christopher
    Pinello, Luca
    Michor, Franziska
    Hata, Aaron N.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [25] Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
    Shahnam, Adel
    Davis, Alexander
    Brown, Lauren Julia
    Sullivan, Isaac
    Lin, Kevin
    Ng, Chien
    Yeo, Nicholas
    Kong, Benjamin Y.
    Khoo, Trisha
    Warburton, Lydia
    Da Silva, Ines Pires
    Mullally, William
    Xu, Wen
    O'Byrne, Ken
    Bray, Victoria
    Pal, Abhijit
    Mersaides, Antony
    Itchins, Malinda
    Arulananda, Surein
    Nagrial, Adnan
    Kao, Steven
    Alexander, Marliese
    Lee, Chee Khoon
    Solomon, Benjamin
    John, Thomas
    LUNG CANCER, 2025, 201
  • [26] The immunotherapy role in patients (pt) with KRAS mutated metastatic non-small cell lung cancer (NSCLC): Differences between KRAS G12C and non-G12C
    Notario Rincon, L.
    Pous, A.
    Lopez-Paradis, A.
    Cerda, G.
    Cucurull, M.
    Hernandez, A.
    Domenech, M.
    Carcereny, E.
    Moran Bueno, M. T.
    Munoz, A.
    Mate, J. L.
    Sanz, C.
    Saigi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S50 - S50
  • [27] Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian J.
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konji, Selma
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 727 - 728
  • [28] Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
    Si-Yang Liu
    Hao Sun
    Jia-Ying Zhou
    Guang-Ling Jie
    Zhi Xie
    Yang Shao
    Xian Zhang
    Jun-Yi Ye
    Chun-Xiang Chen
    Xu-Chao Zhang
    Qing Zhou
    Jin-Ji Yang
    Yi-Long Wu
    Biomarker Research, 8
  • [29] Targeting WEE1 to improve the therapy of KRAS G12C mutant non-small cell lung cancer
    Yamamoto, Gaku
    Tanaka, Kosuke
    Kamata, Ryo
    Mori, Shunta
    Liu, Jie
    Yamauchi, Toyohiro
    Sakae, Yuta
    Ohashi, Akihiro
    Kobayashi, Susumu S.
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
12345